Tech CEO. Impact Entrepreneur. Trailblazer.
Pelin Thorogood is an analytics industry executive turned impact entrepreneur who has made a career out of being at the forefront of emerging business trends and disruptive technologies.
With an unwavering focus on data and analytics, Pelin served as CEO and Director of Anametrix, a venture-backed multichannel data collection, visualization, and predictive analytics platform which received broad industry recognition, including for best business intelligence (BI) and Big Data solution (acquired by Ensighten 2014). Prior to Anametrix, she was CMO of WebSideStory, the pioneer in web analytics (IPO 2004, acquired by Omniture/Adobe 2008).
Pelin is the Co-Founder and President of Wholistic Research, and Education Foundation, one of the very first non-profits (501c3) focused on funding cutting-edge cannabinoid research and education to improve public health and safety. With a deep commitment to education and community, Pelin also serves as a Trustee and Treasurer of the UC San Diego Foundation and is on the Executive Board of the UC San Diego Basement, a campus-wide incubator for innovation and entrepreneurship. Pelin earned her B.S., M.Eng. and MBA degrees on merit scholarships, all from Cornell, where she still serves as an Industry Scholar for Cornell Institute of Healthy Futures.
Scientist. Impact Entrepreneur. Storyteller.
Dr. Jeff Chen is the Co-founder and CEO of Radicle Science. He’s the Founder and former Exec Director of the UCLA Cannabis Research Initiative (one of the world’s 1st), which he grew to encompass over 40 faculty conducting research, education, and policy projects.
Jeff has experience as Founder, Managing Partner, Investor, Board Member, and Advisor to companies, not-for-profits, and venture firms in life science, sustainability, tech, and media. Dr. Chen has been featured in Rolling Stone, Wall Street Journal, VICE, CNN, TIME, NPR, Entrepreneur, Business Insider, Politico, and he’s part of the Medical Team at Healthline Media (86M visitors/month). He’s a David Geffen Fellow, U.S. patent holder, Industry Mentor for the U.S. National Institutes of Health Innovation CORPs, and Chief Science Officer of the Wholistic Research and Education Foundation
Jeff earned his MD and MBA concurrently at UCLA on a full merit scholarship, following a B.S. at Cornell.
Entrepreneur. Business-driven software visionary. Believer in digital & natural health.
As the CTO of Radicle Science, Sheldon’s focus is on the imagining and creation of innovative, scalable, user-friendly, and secure software for growth and customer happiness. His knowledge and experience with healthcare, cloud, data analytics, security, applied AI, and software development team leadership is being leveraged at Radicle to support goals and customer needs.
Sheldon has been a technical and business leader at numerous start-ups and contributed his expertise to multiple IPOs. While at WebMD, he held multiple senior technical leadership roles, including Chief Security Officer (startup through IPO to $1B/yr revenue). He has developed major clinical trials systems, electronic medical record systems, and payment systems including Medicare Advantage. He has been an advisor to several digital health startups leading to successful corporate acquisitions and is a long-term mentor and judge at the MassChallenge accelerator.
Sheldon earned his PhD, EE, and SM degrees from MIT (his Master’s thesis actually got him the PhD), was a real rocket scientist at MIT Draper, and practices Tai Chi (previously figure skating, ice dance, and Tae Kwon Do). However, he is most proud of supporting his family in every possible way.
Art & Science Mixologist. Healthcare Executive. Wellness Enthusiast.
Dr. Michelle L. Shuffett joined Radicle Science as a founding team member and Chief Growth Officer. She is an accomplished healthcare executive, marketing strategist, speaker, and wellness enthusiast with over 20 years of experience encompassing a unique blend of clinical medicine, communications, and leadership.
Michelle is adept at mixing the art and science of medicine and passionate about integrated, wellness-focused opportunities that optimize overall health and happiness. Her expertise lies at the intersection of health and wellness, and spans the pharmaceutical industry; medical education and advertising; digital health marketing and publishing; digital fitness and wellness platforms; and medical cannabis. Her thoughtful approach results in data-driven, strategic insights and holistic solutions.
Much of her recent work has been in the cannabis industry, highlighting the potential health benefits of cannabis and CBD. In her role as VP Scientific Research and Communications at Columbia Care, she strove to change perspectives on cannabis by elevating and validating cannabis research and increasing awareness of the industry as a whole through education. Several of her research projects included analyses related to the impact of medical cannabis on opioid use.
As a founding team member of Radicle Science, she is dedicated to uncovering the objective health outcome data behind natural health products. At its core, Radicle is a Rebellion against the status quo of healthcare and research and a Movement towards democratized, personalized medicines that have the potential to deliver well-being for all future generations.
Michelle attended medical school at the University of Kentucky, completed her residency at UCLA, and practiced at Children’s Hospital Los Angeles. She also attended the London School of Economics, earning certifications in Healthcare Economics and Quantitative Analysis.
Curious. Futurist. Digital Transformation Agent.
Ted joined Radicle Science as a founding team member and Chief Operating Officer/Chief Financial Officer. He has over 30 years of investment and management experience in industries ranging from venture technology to established natural resource and industrial companies.
Ted has served in CEO, COO, and CFO roles in startups and mature companies, both domestically and internationally. And has been an active investor and board member for over 25 companies ranging from digital transformation technologies, media and marketing application services, manufacturing, real estate, and medical devices.
Rebel With a Cause. Tech Enthusiast. Dog Lover.
Throughout her 25-year career in research, Emily has worked tirelessly to expedite the research process to improve the human condition. She is passionate about harnessing the power of technology to streamline the research process, disrupt the status quo, and lessen the burden on trial participants. Emily joined Radicle Science as a founding team member after providing operational and research expertise as a consultant.
Emily’s approach to health and wellness is wholistic, incorporating exercise, nutrition, and relaxation into her daily routine! She is an aerial yoga enthusiast, Lagree® Pilates junkie, and meditates daily. She is often found wherever there are dogs, is always up for a hike, or ready to hit the slopes snow skiing in winter. Emily loves to make (and enjoy) healthy meals with family and friends, trying new recipes inspired from her global travels. On the flip side, she is the ‘team scientist’ for an all-female BBQ team (Boob-B-Q) that has more than one trophy to back up their “Spicy Racks & Smokin’ Thighs” smack!
Altruist. Change Agent. Truth Seeker. Human Potential.
Leo joined Radicle Science as VP of Brand Partnerships after supporting the company as an advisor in its early stages. He is a seasoned business development and cannabis executive, strategist, designer, and human performance enthusiast.
Leo’s experience spans several countries in the cannabis and technology industries, and includes advising companies on their financing strategies, M&A activities, and go-to-market campaigns. He is passionate about the enhancement of human performance using nootropics, novel supplements, adaptogens, and herbal compounds. He is dedicated to the research and validation of these substances to unlock their full potential while providing a safe and clean mode of consumption.
Equality, diversity and inclusion are the core tenets of Leo’s mission to enable people to access affordable and safe medicines and increase the agency they have over their health.
Customer success driven. Organizer. Life-long Learner.
Meghan is passionate about natural health and healing, as well as empowering individuals to make informed choices. She’s also driven to build streamlined systems for optimal flow. Her goal is to create a seamless experience for clients as well as participants as they engage with Radicle Science. Meghan thrives on building relationships, creating operational efficiencies, coordinating cross-functional teams, and leaving no detail unchecked.
Before joining Radicle Science, Meghan was the Director of Customer Engagement at Aisle Planner, a cloud-based project and business management tool in the Wedding and Event industry. Meghan was employee #3 and involved in all aspects of system creation, tracking feedback, prioritizing the development schedule, regression testing, bug replication/reporting, as well as training, onboarding, and retaining users. She also ran an education-related non-profit for several years, and prior to that worked in project management and business development at Proflowers.com.
Meghan earned her MBA at the University of Washington and a BA at UC Santa Barbara. When not working, Meghan loves hiking, backpacking, cooking, yoga, breathwork/meditation, hanging with her 2 teens, tennis, reading, volunteering, and going to concerts and festivals.
Data scientist. Translates health data into actionable insights. Gamer, with a love of chess.
Armin Jamshidi, MS, is a data scientist and machine learning expert who joined Radicle Science as the Director of Data Science. He is deeply passionate about the impact of machine learning applications on health data, and is channeling that passion at Radicle to directly impact the wellbeing of people through personalized medicine for the population at large.
While at UC San Diego, Armin gained experience in the healthtech space by working as a deep learning researcher focused on semantic segmentation for musculoskeletal MRI imaging. He supported a database of medical images and deployed a method to analyze image data over time to determine musculoskeletal health. The software was then leveraged across multiple infrastructures.
Outside of work, Armin loves to go bouldering, play chess, and also explore the city of Los Angeles with his newfound passion for film photography.
Armin earned his BS in Electrical and Electronics Engineering and MS in Machine Learning and Data Science at UC San Diego.
Epidemiologist. Behavioral Scientist. New Mom.
Jessica Saleska, PhD, MPH is an epidemiologist and behavioral scientist. She is deeply interested in using insights from psychology, behavioral economics and human-centered design to foster positive experiences and behaviors, particularly in people’s encounters with the healthcare system and health research. She is presently a postdoctoral fellow at UCLA’s Semel Institute of Neuroscience and Human Behavior. When not working, she loves to trail run, listen to behavioral science podcasts and hang out outside with her husband and (brand new!) baby.
Entrepreneur. Executive.
Bruce is an entrepreneur and executive with a depth and breadth of experience across big data, AI/analytics, and fin-tech. Previously, Bruce was Co-founder, Chairman, and CEO of ID Analytics (acquired by LifeLock for $200+ million) and President of HNC Software Inc. (NASDAQ: HNCS), a $1 billion+ global AI software provider in financial services, telecom and healthcare (acquired by FICO in 2002). Bruce served as Director at 3 public and 7 VC and private-equity backed firms, and was named Ernst & Young’s Entrepreneur of the Year (San Diego) and the Los Alamos National Laboratory’s Entrepreneur of the Year.
Impact entrepreneur. Creator. Investor.
Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world’s leaders on exponentially growing technologies. As an entrepreneur, Diamandis has started over 25 companies in the areas of longevity, space, venture capital and education. He is cofounder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company. Diamandis is a New York Times Bestselling author of two books: Abundance – The Future Is Better Than You Think and BOLD – How to go Big, Create Wealth & Impact the World. His newest book in this series of exponential technologies—The Future is Faster Than You Think—was released in 2020. He earned degrees in molecular genetics and aerospace engineering from the MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “the best way to predict the future is to create it yourself.”
Regulatory Expert.
Martin is a partner at Hogan Lovells and is one of the nation’s top FDA, food and dietary supplement regulatory attorneys. Over the last decade he has been recognized by Super Lawyers, Best Lawyers in America, and Chambers USA for categories including Food and Beverage Law, FDA Law, Food and Drugs, and Food & Beverage Regulatory & Litigation.
Our advisory team brings together experts from the cutting edge of science, technology, health and beyond to support our mission to offer the first ever path to natural medicine validation.
Former Chief Science, Health and Regulatory Officer for The Coca-Cola Company Founder/Principal of FairHaven451
Dr. Rhona S. Applebaum is a widely recognized and deeply experienced leader at the nexus of industry, government, and civil society, acquired from 40 years of distinguished activity in the food and beverage sector. Based on her insights and ability to identify emerging issues, knowledge of evidence-based science, regulatory policy and dedication to their fair application, Rhona excels at building strong relationships across public and private sectors alike.
Serving most recently as The Coca-Cola Company’s first Chief Science and Health Officer, Rhona developed and executed the Company’s global health and well-being strategy. She served as a credible and effective public voice for policy, using her expertise in food safety, nutrition and health and her ability to engage diverse audiences, to build understanding and consensus around critical health and industry issues. Previously Rhona was Executive Vice President and Chief Science Officer for the National Food Processors Association (NFPA), where she was responsible for the overall direction of NFPA’s three laboratory centers, the Office of Food Safety Programs and NFPA’s Research Foundation. Earlier she held leadership positions with the Distilled Spirits Council of the United States, the Chocolate Manufacturers Association, the American Cocoa Research Institute, and the National Confectioners Association.
Rhona has held numerous high-level public assignments, with service on the Dept of State’s Advisory Committee on Int’l & Economic Policy, CDC Foundation’s Roundtable on Global Health Threats, the Harvard Medical School Global Health Advisory Council, Center for Strategic & International Studies Commission on Smart Global Health Policy and various Advisory Boards for the USFDA and USDA. She has also held significant Board and Executive Leadership roles including the International Life Sciences Institute, the International Food Information Council, Georgia Governor Deal’s Advisory Council on Childhood Obesity, Georgia Shape and Health Connect South. She received her BA from Wilson College in history and biology, a Master’s degree in nutrition and food science from Drexel University and a Ph.D. in food microbiology and food safety from the University of Wisconsin.
Rhona currently serves as a member of several international and science advisory boards including The Rollins School of Public Health-Emory University, ANCORED Communications, The Council for Federal Cannabis Regulation, and Radicle Science. Through FairHaven451, an LLC she founded in 2016, she also provides regulatory science insights, guidance, policy advice and strategic solutions to the food and supplement sectors.
Jonathan is Professor at the Jonathan Fielding School of Public Health at UCLA, former Director of the Los Angeles Department of Public Health and was appointed by President Obama to the National Advisory Group on Prevention, Health Promotion and Integrative Public Health.
Sherry is Medical Director at United Healthcare, an entrepreneur,and was previously President of the San Diego County Medical Society. She is a political activist for physicians and the patients they serve, as well as Associate Professor at University of California San Diego.
Cannabinoid expert. Life sciences & investment professional. Drug development strategist.
Rosemary Mazanet, MD, PhD, began advising Columbia Care in 2013. She joined its Scientific Advisory Board as its Chair in 2015 and became its Chief Scientific Officer in 2017.
Rosemary trained in Internal Medicine and Oncology at the Brigham and Women’s Hospital/Dana Farber Cancer Institute before starting her industry career at Amgen in the early 1990s as the head of Clinical Research. At Amgen, Rosemary was given broad responsibilities as one of the first US trained clinician scientists in her field, where she led multiple successful product development initiatives (4 INDs and sBLAs, one BLA, CE mark and IDE) including FDA panel presentations.
Rosemary moved into public equity in 1998 when she joined Oracle Partners LLC in New York as a General Partner. Since that time, she has been a presence in public and private equity biotech and specialty pharma investments, most recently as a General Partner of Apelles Investment Management. In addition to serving as a life sciences management and investment professional, Rosemary has served as a C-suite executive at several biopharma companies and led development programs ranging from IND submission through NDA approval and commercial launch. Her ability to conceive, articulate and execute strategic development and financial vision in public and private company environments enables her to guide Columbia Care’s research efforts, including at many of the top national academic sites.
Among the many boards she is on, Rosemary is a Charter Trustee at the University of Pennsylvania School of Medicine and is the Co-Chair of the Leonard Davis Institute Executive Advisory Board at Wharton.
Former FDA Senior Advisor for Science Innovation and Policy. Former Director, Office of Innovative Scientific Research Technologies, U.S. National Institute of Allergy and Infectious Diseases. Founder/CEO of MyOwnMed (patient-centric clinical trial tech platform).
Katharina is CEO and Founder of OccamzRazor, an organization using computational drug discovery to create a cure for neurodegenerative diseases. She was Stanford’s first Ph.D. in Stem Cell Biology and Regenerative Medicine, which she achieved in record time, and was listed in MIT’s 35 under 35 innovators and Forbes’ 30 under 30.
Jaclyn is a food and consumer products quality and safety systems engineer and Executive Director of Clean Label Project, a national non-profit and standards development organization with the mission to bring truth and transparency to food and consumer product labeling.
Before coming to Clean Label Project, Jaclyn held numerous technical, standards development, food safety, quality, and executive roles within the World Health Organization Collaborating Centre, NSF International. Her expertise is in organic, gluten-free, non-gmo labeling, food safety, and label claim substantiation and compliance.
Michael is an experienced community builder and culture marketer with expertise in building brands via nontraditional marketing channels. He is Co-founder and Partner of Trailblazers, a cannabis executive leadership think tank. Michael is also Co-founder and Partner of OpenNest, a cannabis venture studio with a diversified portfolio of consumer products, media and technology businesses that are driving cannabis adoption as a force for positive change.
Previously, Michael led partnerships and growth at TikTok, the world’s most downloaded app in 2018 with over 2B downloads. He holds an MBA from UCLA Anderson. As Chief Community Officer of Wholistic, Michael focuses on unique collaborations between cannabis industry leaders and top academic research institutes.
Charlie is a Media Executive and Film Producer of titles including Air Force One and Bring It On. His film and stage enterprises generated more than $2 billion in revenue and he is a production partner to Kevin Costner and Harrison Ford, as well as a former board member of the National Basketball Association.
“Optimism can take you anywhere.” Tyler is a community builder, business development executive and creative director who is passionate about using business as a tool to drive positive social change.
Today, he spends his time as the Co-founder of Trailblazers Presents, a cannabis leadership platform, and the CEO of OpenNest Labs, a cannabis venture studio in Los Angeles, CA. Tyler is an active investor and advisor to many great companies including: Calm, Seed, Radicle Science, Bubble, Breathwrk, Luce Farm, 42 Birds, and TheFund. Previously, he was Managing Curator and Head of Business Development at Summit Series, a globally recognized event series for today’s brightest leaders.
Tyler is dedicated to using his resources and network to drive impact as a board member of The Life is Good Kids Foundation and Wholistic Research and Education Foundation. He is an outdoor enthusiast, music lover and enjoys a cold Vermont IPA. Tyler lives in Los Angeles with his wife Tori and son Apollo. He holds a BA in Marketing Communications from Johnson & Wales University.
Professor, Psychiatry & Biobehavioral Science, UCLA. Director, UCLA Laboratory of Circadian & Sleep Medicine.
Christopher S. Colwell is a Neuroscientist who has served on the UCLA School of Medicine faculty since he joined the Department of Psychiatry and Biobehavioral Sciences in 1997. He became a Professor in 2008. Dr. Colwell earned his B.S. in Neuroscience from Vanderbilt University in 1985. During this time, he started his research in circadian rhythms under the mentorship of Dr. T. Page. Dr. Colwell earned his Ph.D. in Biology at the University of Virginia in 1991. His laboratory’s research has focused on understanding the mechanisms underlying circadian rhythms in mammals. Dysfunction in the timing these daily cycles is a key symptom in a number of neurological and psychiatric disorders. Better understanding the basic biology of this timing system should result in new therapies to improve the quality of life of these patients and the people who care for them.
Clinical Psychologist & Research Scientist. Adjunct Faculty, California Institute of Integral Studies.
Clinical psychologist and research scientist with 10+ years of experience in neuroscience and mental health research. With a specialization in health psychology, Dr. Laird’s expertise lies in how stress “gets under the skin” to affect mental and physical well-being. Her program of research focuses on designing, evaluating, and improving upon mind-body approaches to improving health and happiness. Dr. Laird earned her M.S. and PhD in Clinical Science from Vanderbilt University and served as a post-doctoral research scholar at the UCLA Semel Institute for Neuroscience and Human Behavior.
Director, Behavioral Sleep Medicine at Scripps Clinic Sleep Center.
Derek Loewy, PhD is a licensed clinical psychologist and board certified sleep medicine specialist. Dr. Loewy received his doctorate at the University of Ottawa, Canada in 1996. He completed a sleep research fellowship at the University of Arizona in 1999 and his sleep medicine fellowship at Stanford University in 2001, where he co-founded the Insomnia Program at the Stanford Sleep Disorders Center. He is currently Director of the Behavioral Sleep Medicine Program at Scripps Clinic Sleep Center in La Jolla, CA. Dr. Loewy’s specialties include cognitive behavioral therapy for insomnia (CBTI) and bright light therapy in the treatment of circadian rhythm sleep disorders.
Neurologist. Psychopharmacologist.
Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science. Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington.
Associate Professor, Psychiatry & Biobehavioral Science, UCLA. Director, UCLA Depression Grand Challenge Innovative Treatment Network Clinical Services. Anxiety Disorder Section Lead, Veterans Affairs Greater Los Angeles Healthcare System.
Dr. Kate Wolitzky-Taylor is an Associate Professor in the Department of Psychiatry and Biobehavioral Sciences, with a primary research appointment as a Principal Investigator in the Integrated Substance Abuse Programs (ISAP). She is also the Director of the ISAP clinical practicum, Director of Clinical Services for the Depression Grand Challenge Innovative Treatment Network, Associate Faculty of the Anxiety and Depression Research Center (ADRC) in the Department of Psychology, and an attending psychologist in the CBT resident rotation at the UCLA Behavioral Health Services (SHIP).
Professor, Behavioral Pharmacology, Johns Hopkins University.
Dr. Vandrey is an experimental psychologist with degrees from the University of Delaware (BA) and University of Vermont (PhD). He is currently a Professor at the Johns Hopkins University Behavioral Pharmacology Research Unit (BPRU). Dr. Vandrey’s research focuses primarily on the impact of route of administration, dose, and chemical composition of cannabis products on resultant drug effects and pharmacokinetics. In addition, Dr. Vandrey has been involved with a broad range of studies related to the risks and benefits of medicinal cannabis use, the effects of cannabis use on sleep, cannabis withdrawal and the treatment of Cannabis Use Disorder, cannabis product testing, and developing measures of cannabis use behavior.
Co-director, Biostatistics, Scripps Research Translational Institute
Senior Staff Scientist, Scripps Research
Jill Waalen joined the Translational Institute at Scripps Research in November 2010 as a biostatistician. She plans to continue her research at Scripps Research while providing biostatistics expertise to investigators at the Translational Institute.
She is the author or co-author of over 45 journal articles, focusing on the genetic epidemiology of hematologic diseases, including the 2010 report titled “More pieces to the iron chelation puzzle,” for Translational Research. In addition to serving on the editorial board of that journal, she is the deputy editor of the American Journal of Preventive Medicine and Associate Director of the U.C. San Diego/San Diego State University (SDSU) General Preventive Medicine Residency. She also is a lecturer in SDSU’s Graduate School of Public Health.
Before applying for medical school at the University of Wisconsin, from which she received her medical degree in 1997, she was a science and medical writer, first at the National Cancer Institute and then at the Medical College of Wisconsin. A graduate of University of California at Santa Cruz’s science communication program, she has continued to write about science. Examples include her 2002 article, “Boosting brain repair,” for the Howard Hughes Medical Institute Bulletin and “Gleevec’s glory days,” in 2001, also for the HHMI newsletter.
Elected a Diplomat of the American Board of Preventive Medicine in 2001, Jill was awarded a bachelor’s degree in Biology and History at Concordia College in Minnesota in 1984 and the master’s degree in Physiology at the University of Wisconsin in 1989. In 2001, she received a Master’s in Public Health from San Diego State University.
"I’ve personally experienced how a data-driven approach can transform entire industries. I co-founded Radicle Science to bring that same evidence-based thinking to advance natural medicine science. It is about time we leverage the power of rigorous health outcome data at scale to inform smarter health and business decisions for all."
"I spent my whole life becoming a physician so I could heal, only to realize our modern medicines were failing so many folks who were suffering. I co-founded Radicle Science to unlock an entirely new category of trusted treatments. Radicle Science is ushering in a new era of effective democratized medicines by validating the health effects of natural products for the first time."
"As an expert speaker, the most common question I get about CBD is “how do I know how much to use and when?” Radicle Science will help answer that by providing rigorous data for the first time in history. These insights will arm health care providers with insights to guide their patients and empower consumers to make smart choices for themselves."
"Beginning as adolescents, we make decisions that have lifelong consequences for our health and well being —and often without the necessary information. Radicle Science gives me the opportunity to help validate natural medicine efficacy for the first time ever to increase our confidence in those all-important choices we each make."
"Spending the first half of my career in genetics & genomics, I realized the power of collaborative research, streamlining processes, and harnessing technology for the greater good. Attempting to apply the same philosophy to oncology drug development, I met opposition... frequently. I joined Radicle Science to disrupt the status quo, leverage the rigor of clinical research without the inefficiencies of traditional models, and bring natural products BACK into the forefront of Western medicine (as it was for centuries prior)."
We’re a highly-experienced team of renowned experts and trailblazers operating at the intersection of digital health, big data, and natural medicines.
Our collective experience in clinical trials, big data and analytics, public health, pharma, FDA and digital marketing bring a new approach to clinical trials and insight generation.
Radicle Science reimagines the traditional pharmaceutical and academic research model to deliver rigorous health outcome data at a fraction of the time and cost.